Delivery Order SPE2DR25D2013-SPE2DR26F5QRN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count bottles) with a ceiling value of $4,586.41. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of December 12, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract is not designated as a set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets (30-count) on November 26, 2025, with a ceiling value of $2,078.58. This firm fixed price delivery order, with an ultimate completion date of November 28, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This competitively awarded, non-set-aside contract carries a ceiling value of $4,574.72 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 13, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30-count). This is a firm fixed price delivery order with a ceiling value of $2,059.94 and an ultimate completion date of June 23, 2025. The contract is unclassified and was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets (30-count packages) valued at $5,019.27. This is a firm fixed price, non-competitive delivery order issued under a larger indefinite delivery contract vehicle. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal medical supply chain, with performance scheduled for completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30 count) valued at $4,336.18. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 4, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count) valued at $4,197.60. The contract was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents a competitive award to AmerisourceBergen's corporate office, with the place of performance located in Conshohocken,...
- The Defense Logistics Agency awarded a $3,162.68 delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30 count) on November 10, 2025, with completion targeted for November 12, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) with a ceiling value of $2,417.59. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 3, 2025. The award was issued on October 31, 2025, and performance will be executed from the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,475.06 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets (30-count supply) on November 25, 2025, with an ultimate completion date of November 26, 2025. The contract employs firm fixed-price pricing and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...
- SPE2DR25D2013Indefinite Delivery Contract
- SPE2DR25D2013-SPE2DR26F5QRNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) on December 3, 2025, with a ceiling value of $2,201.74 and firm fixed pricing. This competitive award, with no set-aside designation, represents a single delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's prime indefinite delivery vehicle, which serves as a comprehensive global pharmaceutical support contract enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. The ultimate completion date for this specific delivery order is December 4, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/2/25 |